Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Technology Industry News IBM initiates $500m Enterprise AI venture fund to boost Generative AI startups IBM has declared the creation of a $500 million venture fund dedicated to bolstering a spectrum of AI… byPallavi MadhirajuNovember 8, 2023